Sippican Capital Advisors Organon & Co. Transaction History
Sippican Capital Advisors
- $126 Million
- Q4 2024
A detailed history of Sippican Capital Advisors transactions in Organon & Co. stock. As of the latest transaction made, Sippican Capital Advisors holds 36,352 shares of OGN stock, worth $596,536. This represents 0.43% of its overall portfolio holdings.
Number of Shares
36,352
Previous 15,230
138.69%
Holding current value
$596,536
Previous $291,000
86.25%
% of portfolio
0.43%
Previous 0.22%
Shares
13 transactions
Others Institutions Holding OGN
# of Institutions
790Shares Held
201MCall Options Held
1.71MPut Options Held
865K-
Black Rock Inc. New York, NY32.6MShares$535 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA30.2MShares$495 Million0.01% of portfolio
-
Pacer Advisors, Inc. Malvern, PA11.2MShares$183 Million0.41% of portfolio
-
Massachusetts Financial Services CO Boston, MA9.76MShares$160 Million0.06% of portfolio
-
State Street Corp Boston, MA8.98MShares$147 Million0.01% of portfolio
About Organon & Co.
- Ticker OGN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 254,330,000
- Market Cap $4.17B
- Description
- Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...